
COMPUGEN LTD
COMPUGEN LTD (CGEN)
WebsitePrice
Market cap
Next catalystExpected 2H 2027Rilvegostomig — biliary tract cancer trials · Phase 3 dataCompany source ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
Partner / License out
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Financial position
Upcoming milestones
Company funding outlook
Financial history
Annual trends
| Reported item | |||||
|---|---|---|---|---|---|
Reported shares and borrowings
Ownership and institutions
| Status | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|